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  CORRELATIONS BETWEEN THE LIPOPHILI-
CITY AND THE INHIBITORY ACTIVITY OF 
DIFFERENT SUBSTITUTED 
BENZIMIDAZOLES 
2-Amino and 2-methylbenzimidazole derivatives were tested in vitro for their 
inhibitory activity against the bacteria Bacillus cereus. The minimum inhibitory 
concentration (MIC) was determined for all compounds. The lipophilicity des-
criptors were calculated by using CS Chem-Office Software, version 7.0. The 
stepwise regression method was used to derive the most significant model as 
a calibration model for predicting the antibacterial activity of this class of com-
pounds. A complete regression analysis resorting to linear and quadratic rela-
tionships was made. Theoretical models were validated by leaving one out 
(LOO) technique, as well as by the calculation of statistical parameters for the 
established models. The best QSAR model for the prediction of an inhibitory 
activity of the investigated series of benzimidazoles was developed. A high 
agreement between the experimental and predicted inhibitory values was ob-
tained. The results indicated that the antibacterial activity could be modeled 
using the lipophilicity descriptor. 
Key words: benzimidazole; antibacterial activity; quantitative structure-ac-
tivity relationship; lipophilicity; in vitro studies; Bacillus cereus. 
 
 
The benzimidazole functional group plays im-
portant roles in numerous bioactive compounds. The 
literature indicated that the benzimidazole nucleus is 
an essential part of many clinically useful chemothe-
rapeutic agents. Currently, benzimidazole derivatives 
are the subject of sustained interest due to the vast 
range of their potential activities. Biologically active 
benzimidazoles have been known for a long time and 
they can act as bacteriostats or bactericides [1-15]. 
For example, thiabendazol, triclabendazole and me-
bendazole are effective anthelmintic agents [16], and 
are, as well as lansoprazole and omeprazole, used as 
antiulcer agents [17,18]. Moreover, compounds con-
taining a benzimidazole ring were found to have anti-
fungal [19-21], antitubercular [22], antioxidant [23,24], 
antiallergic [25,26], and antiparasitic [27] activities. 
Although a variety of benzimidazole derivatives 
are known, the development of new and convenient 
strategies to synthesize more biological active benz-
imidazoles is of considerable interest. The quantita-
                                                 
Corresponding author: S. O. Podunavac-Kuzmanović, Faculty of 
Technology, Bulevar cara Lazara 1, 21000 Novi Sad, Serbia. 
E-mail: sanya@uns.ns.ac.yu 
Paper received: 19 February, 2009. 
Paper revised: 25 March, 2009. 
Paper accepted: 27 March, 2009. 
tive structure–activity relationship (QSAR) study is a 
useful tool for a rational search of bioactive molecu-
les. The success of QSAR method is the possibility to 
estimate the characteristics of new chemical com-
pounds without the need to synthesize and test them. 
This analysis represents an attempt to relate struc-
tural descriptors of compounds with their physicoche-
mical properties and biological activities. It is widely 
used for the prediction of physicochemical properties 
in chemical, pharmaceutical, and environmental sphe-
res. This method includes the data collection, the mo-
lecular descriptor selection, the correlation model de-
velopment, and finally the model evaluation. QSAR 
studies have a predictive ability and simultaneously 
provide a deeper insight into the mechanism of drug 
receptor interactions [28,29]. 
In this context, the aim of the present work was 
to investigate the activity of different substituted benz-
imidazoles against Gram-positive bacteria Bacillus 
cereus and to study the quantitative effect of lipophili-
city on an antibacterial activity. The central objective 
of the study was to select the most significant QSAR 
model which links the structure of these compounds 
with their inhibitory activity. S. O. PODUNAVAC-KUZMANOVIĆ et al.: CORRELATIONS BETWEEN THE LIPOPHILICITY…  CI&CEQ 15 (3) 125−130 (2009) 
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EXPERIMENTAL 
Material and methods 
The structures of the benzimidazoles tested in 
this study are presented in Table 1. All the com-
pounds, except 1 and 8 were synthesized by the ge-
neral procedure described by Vlaović [30]. 2-Amino-
benzimidazole (1) and 2-methylbenzimidazole (8) were 
of analytical reagent grade, commercially available. 
Table 1. The structures of the compounds studied 
N
N
R1
R2
 
Compound R1 R 2 
1  NH2 H 
2  NH2 C 6H5–CH2 
3  NH2 4–CH3–C6H4–CH2 
4  NH2 4–Cl–C6H4–CH2 
5  NH2 C 6H5–CO 
6  NH2 4–CH3–C6H4–CO 
7  NH2 4–Cl–C6H4–CO 
8  CH3 H 
9  CH3 C 6H5–CH2 
10  CH3 4–CH3–C6H4–CH2 
11  CH3 4–Cl–C6H4–CH2 
12  CH3 C 6H5–CO 
13  CH3 4–CH3–C6H4–CO 
14  CH3 4–Cl–C6H4–CO 
Antibacterial investigations 
All the benzimidazole derivatives were evalu-
ated for their in vitro growth inhibitory activity against 
Gram-positive bacteria Bacillus cereus (АТCC 10876). 
Antibacterial activities of the compounds were 
tested by the disc-diffusion method under standard 
conditions using Mueller-Hinton agar medium as des-
cribed by NCCLS [31]. The investigated isolate of 
bacteria was seeded in the tubes with nutrient broth 
(NB). A volume of 1 cm
3 of seeded NB was taken and 
homogenized in tubes with 9 cm
3 of melted (45 °C) 
nutrient agar (NA). The homogeneous suspension 
was poured out into Petri dishes. The discs of filter 
paper (diameter 5 mm) were ranged on cool medium. 
After cooling on formed solid medium, 2×10
-5 dm
3 of 
the investigated compounds (γ = 1000 μg/ml) were 
placed with a micropipette. After the incubation in a 
thermostat at 37 °C for 24 h, inhibition (sterile) zone 
diameters (including disc) were measured (in mm). 
An inhibition zone diameter over 8 mm indicates that 
the tested compound is active against microorga-
nisms. Every test was done in three replications. 
The minimum inhibitory concentration (MIC) was 
obtained by the agar dilution method according to the 
guidelines established by the NCCLS standard M7-A5 
[32]. The MIC of tested benzimidazoles is defined as 
the lowest concentration of the compound at which no 
growth of the strain was observed in a specified pe-
riod of time and under specified experimental condi-
tions. Stock solutions of the compounds were prepa-
red in dimethylformamide (DMF). Further dilutions 
were performed with distilled water. The inoculated 
plates were then incubated at 37 °C for 20-24 h. A 
control, using DMF without any test compound, was 
included. There was no inhibitory activity in the wells 
containing only DMF. The MIC values of the benzimi-
dazoles tested were obtained as μg/ml. For further 
QSAR analyses, negative logarithms of molar MICs 
(log (1/cMIC)) were used. In order to classify the anti-
bacterial activity we established comparisons with an-
tibacterial agents currently employed in a therapeutic 
treatment. The MICs were compared with standard 
discs of ampicillin and gentamicin which were screen-
ed under similar conditions as reference drugs. 
Molecular modeling and log P calculations 
Molecular modeling studies were performed 
using CS Chem-Office Software version 7.0 (Cam-
bridge software) running on a P-III processor [33]. All 
molecules were constructed by using Chem Draw Ul-
tra 7.0 and saved as template structures. For every 
compound, the template structure was suitably chan-
ged considering its structural features, copied to Chem 
3D 7.0 to create a 3-D model and, finally, the model 
was cleaned up and subjected to energy minimization 
using molecular mechanics (MM2). The minimization 
was executed until the root mean square (RMS) gra-
dient value reached a value smaller than 0.1 kcal/mol. 
The Austin Model-1 (AM-1) method was used for re- 
-optimization until the RMS gradient attained the va-
lue smaller than 0.0001 kcal/mol using MOPAC. The 
lowest energy structure was used for each molecule 
to calculate Clog P values by using ChemDraw Ultra 
7.0 (Table 2). 
Table 2. Data of lipophilicity parameters 
Compound  Clog P 
1  0.99 
2  2.96 
3  3.44 
4  3.52 S. O. PODUNAVAC-KUZMANOVIĆ et al.: CORRELATIONS BETWEEN THE LIPOPHILICITY…  CI&CEQ 15 (3) 125−130 (2009) 
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Table 2. Continued 
Compound  Clog P 
5  2.84 
6  3.32 
7  3.39 
8  1.48 
9  3.45 
10  3.94 
11  4.01 
12  3.33 
13  3.81 
14  3.89 
Statistical methods 
The complete regression analysis was carried 
out by PASS 2005, GESS 2006, NCSS Statistical 
Softwares [34]. 
RESULTS AND DISCUSSION 
The values of antibacterial activity of the benz-
imidazole derivatives against the tested Gram-posi-
tive bacteria are summarized in Table 3. The screen-
ing results reveal that reported compounds expressed 
the inhibitory activity against Bacillus cereus. Conse-
quently, the compounds with high log (1/cMIC) are the 
best antibacterials. 
In an effort to determine the role of lipophilicity 
on the inhibitory activity, QSAR studies of title com-
pounds were performed. A set of benzimidazoles con-
sisting of 14 compounds was used for model genera-
tion. Reference drugs were not included in the model 
generation as they belong to a different structural se-
ries. The inhibitory activity data determined as μg/ml 
were first transformed to negative logarithms of molar 
MICs (log (1/cMIC)), which was used as a dependent 
variable in the QSAR study. The lipophilicity parame-
ters were used as independent variables and were 
correlated with the antibacterial activity. An attempt 
has been made to find a structural requirement for the 
inhibition of Gram-positive B. cereus using the QSAR 
Hansch approach on benzimidazole derivatives. To 
obtain the quantitative effects of the lipophilicity para-
meter of benzimidazole derivatives on their antibacte-
rial activity, QSAR analysis with log P was operated. 
Usually, lipophilicity parameters are linearly rela-
ted to pharmacological activity (MICs), but in a more 
general case this relationship is not linear [35]. There-
fore, a regression analysis was made resorting to li-
near and quadratic. The statistical quality of the gene-
rated models, as depicted, is determined by statistical 
measures: correlation coefficient (r), the standard er-
ror of estimation (s), and F-test (Fisher's value) for sta-
tistical significance [36-38]. The correlation coefficient 
(or coefficient of a multiple determination) is a relative 
measure of fit by the regression equation. Correspond-
ingly, it represents the part of the variation in the ob-
served data that is explained by the regression. The 
correlation coefficient values closer to 1.0 represent a 
better fit of the regression. Standard deviation is mea-
sured by the error mean square, which expresses the 
variation of the residuals or the variation about the 
regression line. Thus, the standard deviation is an ab-
solute measure of quality of fit and should have a low 
Table 3. Antibacterial screening summary 
Compound log  (1/cMIC(exp)) log  (1/cMIC(predicted)) Residuals 
1  3.425 3.377 0.048 
2  4.854 4.990 -0.136 
3  4.579 4.443 0.136 
4  4.615 4.416 0.198 
5  4.88 5.069  -0.189 
6  4.604 4.614 -0.010 
7  4.638 4.517 0.121 
8  4.325 4.358 -0.033 
9  4.551 4.427 0.123 
10  3.277 3.381 -0.105 
11  3.313 3.315 -0.002 
12  4.577 4.601 -0.024 
13  3.602 3.770 -0.168 
14  3.637 3.596 0.041 
Ampicillin 4.446  -  - 
Gentamicin 5.787  -  - 
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value for the regression to be significant. The F-test 
reflects the ratio of the variance explained by the mo-
del and the variance due to the error in regression. 
High values of the F-test indicate that the model is 
statistically significant. It is observed that fitting equa-
tions improve when resorting to second order polyno-
mials (Eq. (1)). 
log1/cMIC = -0.799Clog P
2 + 3.976ClogP + 0.224; 
r = 0.971; s = 0.024; F = 92.16  (1) 
For the estimation of the quality with regard to a 
predictive ability of the best model (Eq. (1)), the cross- 
-validation statistical technique has been applied 
(Table 4). 
The simplest and most general cross-validation 
procedure is the leave-one-out technique (LOO tech-
nique). This method uses cross-validated fewer para-
meters: PRESS (predicted residual sum of squares), 
SSY (total sum of squares deviation), r
2
CV and r
2
adj. 
PRESS is an important cross-validation parameter as 
it is a good approximation of the real predictive error 
of the models. Its value, being less than SSY, points 
out that the model predicts better than chance and 
can be considered statistically significant. The pre-
sent models have PRESS << SSY. From the PRESS 
and SSY, r
2
CV can be easily calculated: 
r
2
CV = 1 - PRESS/SSY (2) 
Table 4. Cross-validation parameters (Eq. (1)) 
PRESS SSY PRESS/SSY  r
2
CV  r
2
adj 
0.4064 4.7554  0.0855  0.9145  0.9334 
The high r
2
CV value is indicative of its reliability in 
predicting the inhibitory activity. 
To confirm the predictive power of a model, the 
inhibitory activity of 14 molecules included in the study 
was calculated by model 1, and the values are pre-
sented in Table 3. The data presented in Table 3 
show that the observed and the estimated activities 
are very close to each other. The residual activity (dif-
ference between experimentally observed log (1/cMIC) 
and QSAR calculated log (1/cMIC) is less than equal to 
0.198. Further, the plot of predicted log (1/cMIC) values 
against the observed log (1/cMIC) values also proves 
the superiority of the model expressed by Eq. (1) (Fi-
gure 1). 
The analysis of the results indicates that the an-
tibacterial activity exhibited by tested compounds is 
governed by the lipophilicity parameter, that is, log P. 
It can be concluded that a strong influence of the par-
tition coefficient, log P, is important for the antibac-
terial activity and this parameter is usually related to 
the pharmacological activity. This evidence was clear-
ly described in a lipid theory advanced by Meyer and 
Overton [39,40]. According to this theory, log P is the 
measure of hydrophobicity which is important for the 
penetration and distribution of the drug, but also for 
the interaction of the drug with receptors. 
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Figure 1. Plots of the predicted versus experimentally observed 
inhibitory activity against Bacillus cereus. 
In order to investigate the existence of a syste-
mic error in developing the QSAR models, the resi-
duals of predicted log (1/cMIC) were plotted against the 
observed log (1/cMIC) values (Figure 2). The propaga-
tion of the residuals on both sides of the zero axis in-
dicates that no systemic error in the development of 
regression models exists, as suggested by Jalali-He-
ravi and Kyani [41]. 
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Figure 2. Plot of the residual values against the experimentally 
observed log1/cMIC values 
This analysis represents an attempt to relate 
only lipophilicity descriptors of benzimidazole deriva-
tives with their inhibitory activities. However, there are 
large number of descriptors which could be correlated S. O. PODUNAVAC-KUZMANOVIĆ et al.: CORRELATIONS BETWEEN THE LIPOPHILICITY…  CI&CEQ 15 (3) 125−130 (2009) 
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with an antibacterial activity. In the next step of our 
investigations, we focused our efforts on QSAR ana-
lysis of the above mentioned derivatives using a com-
bination of various physicochemical, steric, electronic 
and structural molecular descriptors. 
CONCLUSIONS 
From the results and discussion made above, 
we conclude that 2-amino- and 2-methylbenzimida-
zole derivatives are effective in vitro against the Gram- 
-positive bacteria Bacillus cereus. QSAR analysis was 
performed to estimate the quantitative effects of the 
lipophilicity parameter, log P, of different substituted 
2-amino and 2-methylbenzimidazole derivatives on their 
inhibitory activity. log P values were calculated for 
each molecule, and a high-quality mathematical mo-
del relating the antimicrobial activity, log (1/cMIC), and 
log  P was defined.. The comparison of linear and 
quadratic relationships showed that the quadratic equa-
tion was more appropriate for the prediction of the an-
tibacterial activity of the investigated class of mole-
cules. The validity of the models has been establish-
ed by the determination of suitable statistical parame-
ters. From the established QSAR, the inhibitory acti-
vity of the benzimidazoles investigated was calcul-
ated and a close agreement between experimental 
and predicted values was obtained. The low residual 
activity and high cross-validated r
2 values (r
2
CV) obser-
ved indicated the predictive ability of the developed 
QSAR models. 
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